封面
市場調查報告書
商品編碼
1935356

成人及兒童血液濃縮器市場按產品類型、最終用戶及地區分類

Adult and Pediatric Hemoconcentrators Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,成人和兒童血液濃縮器市場價值為 1,430 萬美元,預計到 2033 年將達到 1,770 萬美元,2026 年至 2033 年的複合年成長率為 3.3%。

報告覆蓋範圍 報告詳情
基準年: 2025 2026年市場規模: 1430萬美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
預測期(2026-2033年)複合年成長率: 3.30% 預計2033年價值: 1770萬美元

血液濃縮器是醫療設備,由醫護人員或循環系統(操作體外循環機的醫護人員)在手術過程中使用,用於濃縮紅血球並去除血液中多餘的水分。手術期間,患者的全部血液都會流經血液濃縮器。

血液濃縮器在心臟搭橋手術中備受關注,因為它們能為患者提供自身濃縮的全血,從而減少對異體血液和血液製品的需求。它們維持組織供氧所需的血球比容,並透過保存血小板和血漿凝血蛋白來降低術後出血風險。它們透過快速溫和地去除血漿中多餘的水分,同時保留血漿蛋白,從而維持血漿滲透壓。此外,它們還能最大限度地減少利尿劑的使用,而利尿劑可能對某些患者有禁忌症。

市場動態

血液濃縮器被廣泛認為是心臟繞道手術中清除體液的黃金標準。心血管疾病是最常見且危及生命的疾病之一。

例如,根據美國疾病管制與預防中心(CDC)發布的數據,心臟病是美國首要死因。美國每年約有63萬人死於心臟病,約佔所有死亡人數的四分之一。該機構報告稱,美國每40秒就有一名患者突發心臟病。每分鐘,美國至少有一人死於心臟病。

預計北美和亞太等主要地區心血管疾病的高發將推動預測期內對血液濃縮器的需求,並成為推動全球成人和兒童血液濃縮器市場成長的主要因素。

此外,市場上的主要企業正在尋求策略夥伴關係和合作,以擴大其市場佔有率。例如,2016年,Hemocol HPH系列血液濃縮器的製造商MEDIVATORS(Cantel Medical Corporation的子公司)從加拿大分銷商Vantage Endoscopy(Diploma Canada Holdings Ltd.的子公司)收購了內視鏡再處理資產,從而擴大了其在加拿大的直銷業務。

本次調查的主要特點

  • 本報告對成人和兒童血液濃縮器市場進行了詳細分析,並以 2017 年為基準年,給出了預測期(2018-2026 年)的市場規模和復合年成長率。
  • 該報告重點介紹了各個細分市場的潛在商機,並為該市場說明了一個有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、區域前景以及主要企業採取的競爭策略的重要見解。
  • 該研究根據以下參數對全球成人和兒童血液濃縮器市場的主要企業進行了分析:公司概況、財務業績、產品系列、地理分佈、分銷策略、關鍵發展和策略以及未來計劃。
  • 本報告的研究結果將幫助負責人和經營團隊就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球成人和兒童血液濃縮器市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種策略矩陣輕鬆做出決策,這些矩陣用於分析成人和兒童血液濃縮器市場。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、監管與趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • 市場機遇
  • 影響分析
  • 新產品發布和核准
  • 併購情景
  • PEST分析
  • 波特分析
  • 監管情景
  • 救贖方案
  • 流行病學

4. 2026-2033年全球成人及兒童血液濃縮器市場(依產品類型分類)

  • 成人血液濃縮器
  • 兒童血液濃縮器

5. 2026-2033年全球成人及兒童血液濃縮器市場(依最終用戶分類)

  • 醫院
  • 門診手術中心
  • 其他

6. 2026-2033年全球成人及兒童血液濃縮器市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 非洲
    • 中非
    • 南非
    • 北非
  • 中東
    • GCC
    • 以色列
    • 其他中東國家

第7章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Medivators Inc.
    • Terumo Corporation
    • LivaNova, PLC
    • Maquet(a Getinge Group company)
    • Medica SpA
    • Medtronic Plc.

第8章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2483

Adult And Pediatric Hemoconcentrators Market is estimated to be valued at USD 14.3 Mn in 2026 and is expected to reach USD 17.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 14.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 3.30% 2033 Value Projection: USD 17.7 Mn

Hemoconcentrators are medical devices used by healthcare professionals or perfusionist (health care professional who operates heart-lung bypass equipment), to concentrate red blood cells and remove excess fluid from the bloodstream during surgery. During surgery, the entire blood volume of the patient passes through the hemoconcentrator.

Hemoconcentrators is gaining significant traction in cardio bypass surgery, as it reduces the need for homologous blood and blood products by providing patients with their own concentrated whole blood. It maintains the desired hematocrit level for oxygen transport to tissues; it decreases the risk of post-operative bleeding through the retention of platelets and plasma coagulation proteins; it maintains oncotic pressure by retaining plasma proteins while quickly and gently removing excess plasma water; and minimizes the need for diuretic use, which may be contraindicated for some patients.

Market Dynamics

Hemoconcentrators are widely used as gold standard for removal of fluid during cardio bypass surgery. Cardiovascular diseases are the most common and life threatening diseases.

For instance, according to the data published by Centers of Disease Control and Prevention (CDC), heart diseases are the leading cause of death in the U.S. Annually around 630,000 people in the U.S. die from heart diseases, which is around 1 in every 4 deaths. According to the same source in the U.S., one patient suffers from heart attack in every 40 seconds. Each minute, more than one person in the U.S. dies from heart disease.

Such high prevalence of cardiovascular diseases in key regions such as North America and Asia-Pacific is expected to be a major factor propelling demand for hemoconcentrators and drive global adult and pediatric hemoconcentrators market growth over the forecast period.

Furthermore, key players in the market are adopting strategic partnership and collaboration activities for expanding its presence in the market. For instance, in 2016, MEDIVATORS Inc. (a Cantel Medical Corporation company), a manufacturer of Hemocor HPH family hemoconcentrators expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.

Key features of the study

  • This report provides in-depth analysis of adult and pediatric hemoconcentrators market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global adult and pediatric hemoconcentrators market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Medivators Inc., Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica S.p.A, and others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global adult and pediatric hemoconcentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the adult and pediatric hemoconcentrators market

Market Segmentation

  • By Product Type
    • Adult Hemoconcentrators
    • Pediatric Hemoconcentrators
  • By End User
    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Adult and Pediatric Hemoconcentrators Market Companies
    • Medivators Inc.
    • Terumo Corporation
    • LivaNova, PLC
    • Maquet (a Getinge Group company)
    • Medica S.p.A

Table of Contents

1. Research Objectives and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Novel Product Launch/Approval
  • Merger-Acquisition Scenario
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • Epidemiology

4. Global Adult and Pediatric Hemoconcentrators Market, By Product Type, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Adult Hemoconcentrators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Pediatric Hemoconcentrators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Adult and Pediatric Hemoconcentrators Market, By End User, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Adult and Pediatric Hemoconcentrators Market, By Region, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • North America
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country/Region, 2026 - 2033 (USD Mn)
      • Central Africa
      • South Africa
      • North Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medivators Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LivaNova, PLC
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Maquet (a Getinge Group company)
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medica S.p.A
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic Plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact